In this special edition premiere of Post Scrip, host Henry sits down with Dr. Jerry Avorn, MD, Harvard Medical School professor and author of the groundbreaking book Rethinking Medications: Truth, Power and the Drugs You Take. Dr. Avorn, a senior internist at Mass General Brigham and author of over 600 papers, takes us on a dive into the complex world of drug approval, pricing, and pharmaceutical policy. This episode explores how the FDA's accelerated approval pathway, originally designed for...
All content for Post Scrip: The ASPL Pharmacy Law Podcast is the property of American Society for Pharmacy Law (ASPL) and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this special edition premiere of Post Scrip, host Henry sits down with Dr. Jerry Avorn, MD, Harvard Medical School professor and author of the groundbreaking book Rethinking Medications: Truth, Power and the Drugs You Take. Dr. Avorn, a senior internist at Mass General Brigham and author of over 600 papers, takes us on a dive into the complex world of drug approval, pricing, and pharmaceutical policy. This episode explores how the FDA's accelerated approval pathway, originally designed for...
S2E6 - Monet Stanford, PharmD | Post-Scrip: The ASPL Pharmacy Law Podcast
Post Scrip: The ASPL Pharmacy Law Podcast
14 minutes
2 years ago
S2E6 - Monet Stanford, PharmD | Post-Scrip: The ASPL Pharmacy Law Podcast
In this episode of Post-Scrip, Henry introduces Monet Stanford, PharmD. Henry and Monet dive into The Transition of Biosimilar: From Provider-Administered to Pharmacy-Dispensed. The biosimilars industry, which started with the first approval in 2015, is at an inflection point. In the U.S., biosimilars could lead to over $130 billion is savings by 2025, and have been used in over 364 million days of patient therapy. Until this year, most biologics — and, until adalimumab , all non...
Post Scrip: The ASPL Pharmacy Law Podcast
In this special edition premiere of Post Scrip, host Henry sits down with Dr. Jerry Avorn, MD, Harvard Medical School professor and author of the groundbreaking book Rethinking Medications: Truth, Power and the Drugs You Take. Dr. Avorn, a senior internist at Mass General Brigham and author of over 600 papers, takes us on a dive into the complex world of drug approval, pricing, and pharmaceutical policy. This episode explores how the FDA's accelerated approval pathway, originally designed for...
